At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 13 enrolled
Drug / intervention
SK3530 100mg, Placebo, Amlodipinedrug
Likely dose
SK3530 100mg, Placebo, Amlodipinefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine
In Brief
A Phase 1 clinical trial evaluating SK3530 100mg, Placebo, Amlodipine for Hypertension. Completed, enrolled 13 participants across 2 sites.
Detailed Summary
To assess the pharmacodynamic effects of co-administrated SK3530 (PDE5 inhibitor) and Amlodipine, phase I study in Hypertensive patient was designed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesSouth Korea
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2008
Enrollment StartMay 2008
Primary CompletionMay 2009
Study CompletionJul 2011
TodayJul 2026
First PostedFeb 29, 2008
Enrollment StartMay 1, 2008
Primary CompletionMay 1, 2009
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.3 years ago
Interventions
SK3530 100mg, Placebo, Amlodipinedrug